Výsledky vyhledávání

Akademický článek

Improving Outpatient Follow-Up Rates for New In-Hospital Consults.

Autor: Stanisce L; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A., Ahmad N; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A., Solomon DH; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A., Kolia N; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A., Garcia LD; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A., Spalla TC; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A., Gaughan JP; Cooper Research Institute, Cooper University Health Care, Camden, New Jersey, U.S.A., Koshkareva Y; Division of Otolaryngology-Head and Neck Surgery, Cooper University Health Care, Camden, New Jersey, U.S.A.

Publikováno v: The Laryngoscope [Laryngoscope] 2023 Oct; Vol. 133 (10), pp. 2540-2545. Date of Electronic Publication: 2022 Dec 13.

Zobrazit plný text záznamu

Akademický článek

Removal of saxitoxin and anatoxin-a by PAC in the presence and absence of microcystin-LR and/or cyanobacterial cells.

Autor: Rorar J; Department of Civil Engineering, The University of Akron, OH 44325-3905, USA., Garcia LD; Department of Civil Engineering, The University of Akron, OH 44325-3905, USA., Cutright T; Department of Civil Engineering, The University of Akron, OH 44325-3905, USA. Electronic address: tcutrig@uakron.edu.

Publikováno v: Journal of environmental sciences (China) [J Environ Sci (China)] 2023 Jun; Vol. 128, pp. 161-170. Date of Electronic Publication: 2022 Aug 18.

Zobrazit plný text záznamu

Akademický článek

Characterization of Novel Derivatives of MBQ-167, an inhibitor of the GTP-binding proteins Rac/Cdc42.

Autor: Medina JI; Department of Biochemistry, School of Medicine, University of Puerto Rico, San Juan, PR., Cruz-Collazo A; Department of Biochemistry, School of Medicine, University of Puerto Rico, San Juan, PR., Del Mar Maldonado M; Department of Biochemistry, School of Medicine, University of Puerto Rico, San Juan, PR., Gascot TM; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, San Juan, PR., Borrero-Garcia LD; MBQ Pharma, Inc., San Juan, PR., Cooke M; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kazanietz MG; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., O'Farril EH; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, San Juan, PR.; MBQ Pharma, Inc., San Juan, PR., Vlaar CP; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, San Juan, PR.; MBQ Pharma, Inc., San Juan, PR., Dharmawardhane S; Department of Biochemistry, School of Medicine, University of Puerto Rico, San Juan, PR.; MBQ Pharma, Inc., San Juan, PR.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Dec; Vol. 2 (12), pp. 1711-1726. Date of Electronic Publication: 2022 Dec 29.

Zobrazit plný text záznamu

Report

Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2.

Autor: Hayashi JY; Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Simizo A; Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Miyamoto JG; Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Costa LVS; Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Souza OF; Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Chiarelli T; Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Bacarov NBS; EUROIMMUN Brasil, São Caetano do Sul, Brazil., Hidalgo R; EUROIMMUN Brasil, São Caetano do Sul, Brazil., Garcia LD; EUROIMMUN Brasil, São Caetano do Sul, Brazil., Soane MM; EUROIMMUN Brasil, São Caetano do Sul, Brazil., Braconi CT; Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Maricato JT; Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Janini LM; Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Salomão R; Division of Infectious Diseases, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, São Paulo, Brazil., Popi AF; Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Glezer I; Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil., Bonetti T; Division of Gynecology, Department of Medicine, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, São Paulo, Brazil., Tashima AK; Department of Biochemistry, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil. Electronic address: aktashima@unifesp.br.

Publikováno v: The Journal of infection [J Infect] 2022 Jun; Vol. 84 (6), pp. 834-872. Date of Electronic Publication: 2022 Feb 27.

Zobrazit plný text záznamu

Akademický článek

Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.

Autor: Cruz-Collazo A; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Ruiz-Calderon JF; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Picon H; MBQ Pharma, Inc., San Juan, Puerto Rico., Borrero-Garcia LD; MBQ Pharma, Inc., San Juan, Puerto Rico., Lopez I; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Castillo-Pichardo L; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Del Mar Maldonado M; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Duconge J; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Medina JI; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Bayro MJ; Molecular Sciences Research Center, Department of Chemistry, University of Puerto Rico, Rio Piedras Campus, San Juan, Puerto Rico., Hernández-O'Farrill E; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Vlaar CP; Department of Pharmaceutical Sciences, School of Pharmacy, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico., Dharmawardhane S; Department of Biochemistry, School of Medicine, University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico. su.d@upr.edu.; MBQ Pharma, Inc., San Juan, Puerto Rico.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Dec; Vol. 20 (12), pp. 2420-2432. Date of Electronic Publication: 2021 Oct 04.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání